Mercury Laboratories Yönetim

Yönetim kriter kontrolleri 3/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Rajendra Shah

İcra Kurulu Başkanı

₹1.9m

Toplam tazminat

CEO maaş yüzdesi	69.9%
CEO görev süresi	42.8yrs
CEO sahipliği	24.6%
Yönetim ortalama görev süresi	1.4yrs
Yönetim Kurulu ortalama görev süresi	8.3yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Rajendra Shah'un ücretlendirmesi Mercury Laboratories'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	₹40m
Jun 30 2024	n/a	n/a	₹50m
Mar 31 2024	₹2m	₹1m	₹57m
Dec 31 2023	n/a	n/a	₹41m
Sep 30 2023	n/a	n/a	₹35m
Jun 30 2023	n/a	n/a	₹51m
Mar 31 2023	₹2m	₹1m	₹56m
Dec 31 2022	n/a	n/a	₹62m
Sep 30 2022	n/a	n/a	₹61m
Jun 30 2022	n/a	n/a	₹39m
Mar 31 2022	₹2m	₹1m	₹36m
Dec 31 2021	n/a	n/a	₹34m
Sep 30 2021	n/a	n/a	₹49m
Jun 30 2021	n/a	n/a	₹56m
Mar 31 2021	₹2m	₹1m	₹53m
Dec 31 2020	n/a	n/a	₹43m
Sep 30 2020	n/a	n/a	₹38m
Jun 30 2020	n/a	n/a	₹32m
Mar 31 2020	₹2m	₹1m	₹32m
Dec 31 2019	n/a	n/a	₹38m
Sep 30 2019	n/a	n/a	₹33m
Jun 30 2019	n/a	n/a	₹30m
Mar 31 2019	₹2m	₹2m	₹28m
Dec 31 2018	n/a	n/a	₹30m
Sep 30 2018	n/a	n/a	₹33m
Jun 30 2018	n/a	n/a	₹42m
Mar 31 2018	₹2m	₹2m	₹20m

Tazminat ve Piyasa: Rajendra 'nin toplam tazminatı ($USD 22.14K ), Indian pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 42.63K ).

Tazminat ve Kazançlar: Rajendra 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Rajendra Shah (72 yo)

42.8yrs

Görev süresi

₹1,866,000

Tazminat

Mr. Rajendra Ramanlal Shah has been the Managing Director of Mercury Laboratories Limited since March 31, 1992 and serves as its Chief Executive Officer and served as its Chairman of the Board until Februa...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Rajendra Shah	CEO, MD & Director	no data	₹1.87m	24.56% ₹ 272.6m
Ashish Vasavada	Chief Financial Officer	3.1yrs	₹1.43m	Veri yok
Saurabh Mittal	Chief Operating Officer	less than a year	₹3.62m	Veri yok
Krishna Shah	Company Secretary & Compliance Officer	2.8yrs	₹403.00k	Veri yok
Paresh Mistry	Non Executive Non Independent Director & MD of Purchase	no data	₹1.44m	Veri yok
Mukesh Shrivastava	Vice President of Marketing & Sales	no data	Veri yok	Veri yok
Kinjal Upadhyay	HR Manager	1.3yrs	Veri yok	Veri yok
Jagdish Patil	Head of Injectable Production Department	less than a year	Veri yok	Veri yok
Sandip Patel	Plant Head of Liquid & Tablet	1.5yrs	Veri yok	Veri yok
Shilpi Bhatnagar	Quality Assurance Head	no data	Veri yok	Veri yok

1.4yrs

Ortalama Görev Süresi

54yo

Ortalama Yaş

Deneyimli Yönetim: 538964 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1.4 yıl), bu da yeni bir ekibin varlığını gösteriyor.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Rajendra Shah	CEO, MD & Director	42.8yrs	₹1.87m	24.56% ₹ 272.6m
Paresh Mistry	Non Executive Non Independent Director & MD of Purchase	7.1yrs	₹1.44m	Veri yok
Dilipbhai Shah	Non-Executive Non Independent Director	42.8yrs	₹29.00k	34.24% ₹ 380.1m
Bharat Mehta	Non-Executive Independent Chairman	9.5yrs	₹47.00k	Veri yok
Janki Shah	Non Executive Non Independent Director	4.8yrs	₹27.00k	8.67% ₹ 96.2m
Jayantilal Raval	Non-Executive Independent Director	less than a year	Veri yok	Veri yok

8.3yrs

Ortalama Görev Süresi

70.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 538964 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 8.3 yıldır).

Mercury Laboratories Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

Mercury Laboratories Limited, Annual General Meeting, Sep 27, 2024

Mercury Laboratories Limited Announces Promotion of Saurabh Mittal as Chief Operating Officer

Mercury Laboratories Limited, Annual General Meeting, Sep 27, 2023

Insufficient new directors

Mercury Laboratories Limited, Annual General Meeting, Sep 27, 2022

Mercury Laboratories Limited Appoints Janki R Shah as Director

Recent updates

Second quarter 2025 earnings released: EPS: ₹4.17 (vs ₹12.56 in 2Q 2024)

Mercury Laboratories Limited to Report Q2, 2025 Results on Nov 14, 2024

Now 30% overvalued after recent price rise

Now 20% overvalued after recent price rise

Upcoming dividend of ₹3.50 per share

Now 25% overvalued after recent price rise

Dividend of ₹3.50 announced

First quarter 2025 earnings released: EPS: ₹2.85 (vs ₹8.33 in 1Q 2024)

Mercury Laboratories Limited, Annual General Meeting, Sep 27, 2024

Mercury Laboratories Limited to Report Q1, 2025 Results on Jul 24, 2024

Now 22% undervalued

Mercury Laboratories Limited Recommends Dividend for the Year 2023-24

Full year 2024 earnings released: EPS: ₹47.12 (vs ₹46.49 in FY 2023)

Mercury Laboratories Limited to Report Fiscal Year 2024 Results on May 28, 2024

Third quarter 2024 earnings released: EPS: ₹10.30 (vs ₹5.05 in 3Q 2023)

Investor sentiment deteriorates as stock falls 16%

Mercury Laboratories Limited to Report Q3, 2024 Results on Feb 12, 2024

Investor sentiment improves as stock rises 20%

Investor sentiment improves as stock rises 19%

Mercury Laboratories Limited Announces Promotion of Saurabh Mittal as Chief Operating Officer

Mercury Laboratories Limited Approves Dividend for the Financial Year Ended March 31,2023

Upcoming dividend of ₹3.50 per share at 0.4% yield

Mercury Laboratories Limited, Annual General Meeting, Sep 27, 2023

First quarter 2024 earnings released: EPS: ₹8.33 (vs ₹12.19 in 1Q 2023)

Investor sentiment improves as stock rises 28%

Full year 2023 earnings released: EPS: ₹46.49 (vs ₹30.72 in FY 2022)

Mercury Laboratories Limited Recommends Dividend for the Year 2022-23

Insufficient new directors

Investor sentiment deteriorates as stock falls 18%

Third quarter 2023 earnings released: EPS: ₹5.05 (vs ₹4.34 in 3Q 2022)

Mercury Laboratories Limited to Report Q3, 2023 Results on Feb 13, 2023

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2023 earnings released: EPS: ₹26.19 (vs ₹8.03 in 2Q 2022)

Second quarter 2023 earnings released: EPS: ₹26.19 (vs ₹8.03 in 2Q 2022)

Mercury Laboratories Limited to Report Q2, 2023 Results on Nov 11, 2022

Mercury Laboratories Limited Approves Dividend for the Financial Year Ended March 31, 2022

Investor sentiment improved over the past week

Upcoming dividend of ₹3.50 per share

Mercury Laboratories Limited, Annual General Meeting, Sep 27, 2022

First quarter 2023 earnings released: EPS: ₹12.19 (vs ₹10.38 in 1Q 2022)

Investor sentiment improved over the past week

Mercury Laboratories Limited Recommends Dividend for the Year 2022

Mercury Laboratories Limited to Report Q4, 2022 Results on May 26, 2022

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS ₹8.03 (vs ₹13.79 in 2Q 2021)

Upcoming dividend of ₹2.00 per share

First quarter 2022 earnings released: EPS ₹10.38 (vs ₹8.01 in 1Q 2021)

Chief Financial Officer Enu Khandelwal has left the company

Full year 2021 earnings released: EPS ₹44.48 (vs ₹26.90 in FY 2020)

Mercury Laboratories Limited Recommends Dividend for Year Ended March 31, 2021

Investor sentiment improved over the past week

Upcoming Dividend of ₹1.50 Per Share

Third quarter 2021 earnings released: EPS ₹16.96 (vs ₹12.73 in 3Q 2020)

Mercury Laboratories Limited to Report Q3, 2021 Results on Feb 11, 2021

Investor sentiment improved over the past week

New 90-day high: ₹510

New 90-day high: ₹473

Market bids up stock over the past week

Market bids up stock over the past week

Mercury Laboratories Limited to Report Q2, 2021 Results on Nov 06, 2020

New 90-day high: ₹453

Mercury Laboratories Limited Appoints Janki R Shah as Director

First quarter earnings released

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat